
Klekovski after the events in oncology: I will not resign
The Director of the Health Insurance Fund (HIF), Sasho Klekovski, stated tonight that he will not resign upon SDSM's demands for his resignation, indicating that the party lacks the credibility to call for accountability.
Recommended
-SDSM, whose leader Venko Filipce did not take responsibility for patients burned alive, is now demanding responsibility, I believe that there is no credibility for that. I would just like to remind you that during their mandate, the greatest abuse, especially of expensive drugs in Oncology, occurred, a devastating situation that still has consequences. And no, I will not resign, because neither by doing or not doing anything I have contributed anything to this situation. On the contrary, I, that is, the Fund and the Clinic, the director, the management and the entire staff, are working hard to overcome the inherited situation. Let me remind you that after seven years of devastation, this management has only been in office for six months, said Klekovski.
Regarding the new situation at the Oncology Clinic, regarding the lack of biological therapy, he explained that out of 5 patients, only a small group lacks a certain therapy and that they are working to eliminate that shortage.
-The director inherited the Oncology Clinic with a 12 million euro debt and all those problems that are yet to be made public. In these six months, the Fund has provided an additional five million euros for the rehabilitation of the financial situation. Another proof that I am not shirking responsibility is that both I and the director are available to the media and the public and we are not hiding, but are here to answer your questions, said Klekovski.
He emphasized that what they want to overcome is through detailed planning at the Clinic, to see which medicine can be purchased with an annex to existing contracts, which medicine can be purchased with a donation while the procurement is being organized, and for some medicines, as he says, they will make direct agreements with the manufacturers, not with the wholesalers.
He says that the Public Prosecutor's Office should comment on the work of Oncology in the past seven years, because, as he says, without clearing up the past, it is difficult to move the situation forward.